Skip to main content
IMMUNOLOGY2026™ Main banner
Final Program


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

Matthew Griffiths, PhD (he/him/his)

VP, In Vitro Biology & Rare Disease Therapeutic Area Lead
Evotec (UK) Ltd

Poster(s):

Email Matthew